Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Jolanta, Stefaniak"'
Autor:
Agnieszka Brodzisz, Magdalena Maria Woźniak, Ewa Dudkiewicz, Dominik Grabowski, Jolanta Stefaniak, Andrzej Paweł Wieczorek, Jerzy Kowalczyk
Publikováno v:
Journal of Ultrasonography, Vol 13, Iss 55, Pp 373-378 (2013)
Introduction: Burkitt’s lymphoma accounts for approximately 25% of lymphomas diagnosed in children of developmental age. The tumor is localized mainly in the intestine (usually in the ileocecal region), mesenteric lymph nodes and extraperitoneal
Externí odkaz:
https://doaj.org/article/f6dce81433254f1a8ab59c0ecc31c45c
Autor:
Dominik Grabowski, Agnieszka Brodzisz, Andrzej Paweł Wieczorek, Magdalena Maria Woźniak, Jolanta Stefaniak, Ewa Dudkiewicz, Jerzy Kowalczyk
Publikováno v:
Journal of Ultrasonography. 13:373-378
Burkitt's lymphoma accounts for approximately 25% of lymphomas diagnosed in children of developmental age. The tumor is localized mainly in the intestine (usually in the ileocecal region), mesenteric lymph nodes and extraperitoneal space. The clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb236ac30f8ac5aec57df209dc834f87
https://doi.org/10.15557/jou.2013.0040
https://doi.org/10.15557/jou.2013.0040
Autor:
Marta Chroma, Jerzy Kowalczyk, Agnieszka Brodzisz, Jolanta Stefaniak, Katarzyna Drabko, Beata Wójcik, Agnieszka Zaucha-Prażmo
Publikováno v:
Reports of Practical Oncology & Radiotherapy. 9:179-182
Summary Rituximab is a human-mouse chimeric monoclonal antibody with specifity for the CD20 antigen expressed on B-lineage cells. We are reporting a 17-year old boy diagnosed with diffuse large B cell lymphoma, CD20(+). He was treated by standard che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a68de1b190f10ed15069d73b3248b4fe
https://doi.org/10.1016/s1507-1367(04)71026-3
https://doi.org/10.1016/s1507-1367(04)71026-3
Autor:
Joanna, Szczepanek, Monika, Pogorzala, Benigna, Konatkowska, Edyta, Juraszewska, Wanda, Badowska, Igor, Olejnik, Marta, Kuzmicz, Elzbieta, Stanczak, Iwona, Malinowska, Jolanta, Stefaniak, Grazyna, Sobol, Tomasz, Szczepanski, Krzysztof, Czyzewski, Mariusz, Wysocki, Jan, Styczynski
Publikováno v:
Anticancer research. 30(6)
The proteasome inhibitor, bortezomib, is known to be effective in the therapy of various neoplasms. The objective of this study was the analysis of the ex vivo activity of bortezomib in paediatric acute lymphoblastic leukaemia (ALL), in comparison to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::17da0cbce64fae8e5def29d3c2ec6255
https://pubmed.ncbi.nlm.nih.gov/20651360
https://pubmed.ncbi.nlm.nih.gov/20651360
Autor:
Jan, Styczynski, Lidia, Gil, Katarzyna, Derwich, Jacek, Wachowiak, Walentyna, Balwierz, Wanda, Badowska, Maryna, Krawczuk-Rybak, Michal, Matysiak, Maria, Wieczorek, Anna, Balcerska, Danuta, Sonta-Jakimczyk, Jolanta, Stefaniak, Jerzy, Kowalczyk, Tomasz, Urasinski, Grazyna, Sobol, Mieczyslaw, Komarnicki, Mariusz, Wysocki
Publikováno v:
Anticancer research. 29(5)
Clofarabine is a second-generation nucleoside analogue. The aim of the study was the analysis of ex vivo activity of clofarabine and 14 other anticancer drugs in pediatric and adult acute lymphoblastic (ALL) and myeloid (AML) leukemia.The ex vivo dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce582b5394d34c969cc68de1cb72c21f
https://pubmed.ncbi.nlm.nih.gov/19443380
https://pubmed.ncbi.nlm.nih.gov/19443380
Autor:
Jacek, Postepski, Agnieszka, Majcher, Violetta, Opoka-Winiarska, Jolanta, Stefaniak, Małgorzata, Kostrzewa
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 60(9-10)
Fevers, arthritis, myalgia and skin changes are the most typical features of rheumatic diseases, although one should remember that the same symptoms could mask neoplasm. This study shows that some patients with rheumatological symptoms treated in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3511f8b6a4de45fe9739cf0abb457809
https://pubmed.ncbi.nlm.nih.gov/18350715
https://pubmed.ncbi.nlm.nih.gov/18350715
Autor:
Adam, Reich, Grazyna, Wróbel, Bernarda, Kazanowska, Jadwiga, Maldyk, Halina, Bubala, Agnieszka, Dluzniewska, Jolanta, Stefaniak, Katarzyna, Stefanska, Malgorzata, Stolarska
Publikováno v:
Acta dermatovenerologica Alpina, Pannonica, et Adriatica. 15(4)
The aim of this study was to demonstrate the clinical spectrum of highly malignant cutaneous non-Hodgkin lymphoma (NHL) in children and to define the outcome among these patients.A retrospective analysis of children with NHL treated at Polish oncolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1722e496913d4262798ad2eee5bfae64
https://pubmed.ncbi.nlm.nih.gov/17982608
https://pubmed.ncbi.nlm.nih.gov/17982608
Autor:
Joanna, Zawitkowska-Klaczyńska, Ewa, Dudkiewicz, Jolanta, Stefaniak, Krzysztof, Katski, Ewa, Bień, Ninela, Irga, Elzbieta, Adamkiewicz-Drozyńska, Anna, Płoszyńska, Czesław, Stankiewicz, Anna, Balcerska, Jerzy, Kowalczyk
Publikováno v:
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 17(101)
About 7% of all childhood cancers comprise non-Hodgkin's lymphoma (NHL). NHL are heterogenous group of neoplasms deriving from lymphatic system (cell B and T). B-cell NHL characterize by high malignancy, but coincidentally good reaction for treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::db2ced67e8e333d1b3bc8a74c700fba2
https://pubmed.ncbi.nlm.nih.gov/15754634
https://pubmed.ncbi.nlm.nih.gov/15754634
Autor:
Małgorzata, Zajaczkowska, Jolanta, Stefaniak, Przemysław, Sikora, Marta, Choma-Smaga, Barbara, Filiks-Litwin, Irena, Szajner-Milart, Halina, Borzecka
Publikováno v:
Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina. 58(1)
The purpose of the study was to estimate the urinary excretion of NAG and alpha-1M among children who suffer from proliferative blood diseases. The group of the examined children included those who went through a viral hepatitis (VH) and who are or w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::81c3f36ff1fd673a16bc1f20df5ab001
https://pubmed.ncbi.nlm.nih.gov/15315013
https://pubmed.ncbi.nlm.nih.gov/15315013
Autor:
Agnieszka, Dłuzniewska, Walentyna, Balwierz, Anna, Balcerska, Alicja, Chybicka, Grzegorz, Dobaczewski, Jerzy, Kowalczyk, Katarzyna, Krenke, Danuta, Lewandowska, Iwona, Malinowska, Michał, Matysiak, Maria, Mikołajczyk, Marek, Niedźwiedzki, Roma, Rokicka-Milewska, Danuta, Sońta-Jakimczyk, Jolanta, Stefaniak, Jan, Styczyński, Renata, Tomaszewska, Jacek, Wachowiak, Mariusz, Wysocki
Publikováno v:
Przeglad lekarski. 60
Results of treatment of childhood ANLL remained unsatisfactory for a long time, and introduction of a new drug seemed justified as the EFS achieved in this disease between 1993-97 was 42%. In 1998 a new protocol containing idarubicine in dose 12 mg/m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9c4e62a9b36e1353e3733589fbc22839
https://pubmed.ncbi.nlm.nih.gov/14575003
https://pubmed.ncbi.nlm.nih.gov/14575003